Opioid use and misuse three months after ED visit for acute pain

Opioid use at the three-month follow-up in emergency department patients discharged with an opioid prescription for acute pain is relatively low and not necessarily synonymous with opioid misuse. That is the conclusion of a study to be published in the August 2019 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM). The lead […]

Read more

Incidence of Acute Myocardial Infarctions Up Among Young Women

MONDAY, Feb. 25, 2019 — The incidence of acute myocardial infarctions (AMI) has increased among younger women, and sedentary time is associated with an increased risk for cardiovascular disease (CVD) among women, according to two studies published in the Feb. 19 issue of Circulation, a “Go Red for Women” theme issue on cardiovascular disease in women. Sameer Arora, M.D., from […]

Read more

Research team identifies a new genetic variant associated with acute respiratory distress

An international collaboration including Javier Belda, professor of surgery at the University of Valencia, has reported a new genetic variant associated with acute respiratory distress syndrome (ARDS). The work, with a sample of more than 2,000 patients, has been published in the Intensive Care Medicine Experimental journal. ARDS is one of the main causes of mortality in adults admitted to […]

Read more

argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia

Breda, the Netherlands / Ghent, Belgium – December 03, 2018 — argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced  that it will share the detailed data from its Phase 2 clinical trial of efgartigimod (ARGX-113) in immune thrombocytopenia (ITP)  and […]

Read more